Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Total revenues	$ 9,956,000	$ 6,780,000
Operating expenses (income):
Cost of revenues	9,802,000	8,708,000
Research and development	1,509,000	3,889,000
(Gain) on sale of Verdeca	(1,138,000)	0
Loss on sale of Arcadia Spain	0	497,000
Impairment of intangible assets	404,000	3,302,000
Impairment of goodwill	0	1,648,000
Change in fair value of contingent consideration	(70,000)	(210,000)
(Gain) on sale of property and equipment	(314,000)	23,000
Impairment of property and equipment, net	530,000	1,534,000
Selling, general and administrative	18,048,000	22,938,000
Total operating expenses	28,771,000	42,306,000
Loss from operations	(18,815,000)	(35,526,000)
Interest income (expense)	289,000	(20,000)
Other income, net	33,000	10,114,000
Change in fair value of common stock warrant and option liabilities	3,209,000	8,946,000
Gain on extinguishment of PPP loan	0	1,123,000
Issuance and offering costs	(314,000)	(769,000)
Net loss before income taxes	(15,598,000)	(16,132,000)
Income tax (provision)	(14,000)	(2,000)
Net loss	(15,612,000)	(16,134,000)
Net loss attributable to non-controlling interest	(236,000)	(1,474,000)
Net loss attributable to common stockholders	$ (15,376,000)	$ (14,660,000)
Net loss per share attributable to common stockholders:
Basic net loss per share attributable to common stockholders:	$ (25.65)	$ (27.56)
Diluted net loss per share attributable to common stockholders:	$ (25.65)	$ (27.56)
Weighted-average number of shares used in per share calculations:
Weighted average shares - Basic	599,389	532,016
Weighted average shares - Diluted	599,389	532,016
Other comprehensive loss	$ 0	$ 0
Comprehensive loss attributable to common stockholders	(15,376,000)	(14,660,000)
Product
Revenues:
Total revenues	8,960,000	6,587,000
License
Revenues:
Total revenues	879,000	17,000
Royalty
Revenues:
Total revenues	$ 117,000	$ 176,000